Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» colorectal cancer
colorectal cancer
Exact Sciences, Guardant rally after Freenome colorectal cancer test results
Tip Ranks
Wed, 04/3/24 - 11:19 am
Medtech
diagnostics
Freenome
EXACT Sciences
Guardant Health
colorectal cancer
liquid biopsy
Gritstone shares fall on shaky study results for colorectal cancer vaccine
BioPharma Dive
Tue, 04/2/24 - 11:36 am
Gritstone Bio
colorectal cancer
clinical trials
cancer vaccines
A simple blood test can detect colorectal cancer early, study finds
NPR
Thu, 03/14/24 - 11:20 am
Guardant Health
diagnostics
Medtech
colorectal cancer
clinical trials
Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset
Fierce Pharma
Sun, 01/21/24 - 05:09 pm
Bristol Myers Squibb
colorectal cancer
Opdivo-Yervoy
AbbVie-backed Disco gets down with €20M to find new targets for antibody-based therapies
Fierce Biotech
Tue, 01/16/24 - 09:14 am
Disco Pharmaceuticals
AbbVie
venture capital
lung cancer
colorectal cancer
Merck KGaA bets on Inspirna’s colorectal cancer drug ompenaclid
Pharmaphorum
Thu, 01/4/24 - 10:09 am
Merck KGaA
Inspirna
colorectal cancer
ompenaclid
Takeda’s Fruzaqla (Fruquintinib) Gets FDA Nod for Metastatic Colorectal Cancer
Xtalks
Thu, 12/21/23 - 09:42 am
Takeda
FDA
colorectal cancer
fruquintinib
Fruzaqla
BMS Builds Case for Opdivo, Yervoy Combo in First-Line Colorectal Cancer
BioSpace
Fri, 12/8/23 - 10:00 am
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
metastatic colorectal cancer
clinical trials
Takeda snares approval for all-comer gastric cancer drug
Medical Marketing and Media
Sun, 11/12/23 - 09:23 pm
Takeda
Fruzaqla
colorectal cancer
Takeda Wins FDA Approval for Fruquintinib in Certain Colorectal Cancer Patients
BioSpace
Thu, 11/9/23 - 09:48 am
Takeda
fruquintinib
FDA
colorectal cancer
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
BioSpace
Fri, 08/4/23 - 12:30 pm
Amgen
oncology
colorectal cancer
small cell lung cancer
tarlatamab
Lumakras
FDA Clears Taiho’s Lonsurf in Metastatic Colorectal Cancer Ahead of Takeda, Hutchmed
BioSpace
Thu, 08/3/23 - 10:23 am
Taiho Oncology
Lonsurf
colorectal cancer
FDA
Takeda
Hutchmed
Exact Sciences’ next-gen colorectal cancer test hits primary goals in pivotal study
Medtech Dive
Wed, 06/21/23 - 11:55 am
EXACT Sciences
Medtech
diagnostics
colorectal cancer
Cologuard
clinical trials
FDA grants priority review for Takeda and HUTCHMED’s fruquintinib NDA
Pharmaceutical Technology
Fri, 05/26/23 - 11:31 am
Takeda
Hutchmed
FDA
fruquintinib
colorectal cancer
Guardant blood test detects 83% of colorectal cancer cases, but fewer in early stage
Medtech Dive
Thu, 05/11/23 - 10:59 am
Guardant Health
diagnostics
Medtech
colorectal cancer
Shield
clinical trials
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
BioSpace
Fri, 04/7/23 - 01:58 pm
Merck
Keytruda
Eisai
Lenvima
melanoma
clinical trials
cancer
colorectal cancer
Takeda focuses on ‘diverse’ pipeline prospects on heels of two acquisitions
Endpoints
Mon, 02/6/23 - 10:55 am
Takeda
Nimbus Therapeutics
Hutchmed
colorectal cancer
psoriasis
fruquintinib
Guardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%
Reuters
Thu, 12/15/22 - 11:13 pm
Guardant Health
DNA
diagnostics
colorectal cancer
EXACT Sciences
Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing
BioSpace
Thu, 10/20/22 - 11:24 pm
Erasca
Pfizer
ERAS-007
Ibrance
colorectal cancer
Pages
1
2
3
4
5
6
7
8
next ›
last »